John P. McLaughlin
2012
In 2012, John P. McLaughlin earned a total compensation of $2.5M as President and Chief Executive Officer at PDL BioPharma, a 118% increase compared to previous year.
Compensation breakdown
| Bonus | $469,000 |
|---|---|
| Non-Equity Incentive Plan | $1,188,050 |
| Salary | $675,000 |
| Stock Awards | $201,000 |
| Other | $10,000 |
| Total | $2,543,050 |
McLaughlin received $1.2M in non-equity incentive plan, accounting for 47% of the total pay in 2012.
McLaughlin also received $469K in bonus, $675K in salary, $201K in stock awards and $10K in other compensation.
Rankings
In 2012, John P. McLaughlin's compensation ranked 2,778th out of 11,487 executives tracked by ExecPay. In other words, McLaughlin earned more than 75.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,778 out of 11,487 | 76th |
Division Manufacturing | 979 out of 4,253 | 77th |
Major group Chemicals And Allied Products | 220 out of 1,203 | 82nd |
Industry group Drugs | 128 out of 925 | 86th |
Industry Biological Products, Except Diagnostic Substances | 21 out of 165 | 87th |
Source: SEC filing on April 16, 2015.
McLaughlin's colleagues
We found four more compensation records of executives who worked with John P. McLaughlin at PDL BioPharma in 2012.